Telling the patients about diagnosis and outcome of schizophrenia: what, when and how?

Farooq, Saeed; Naeem, Farooq; Singh, Swaran P.

doi:10.1111/eip.12310

Cited by 7 publications

(16 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Delay appears to be justified on two grounds. One purported reason is the belief that the diagnosis of schizophrenia is unstable over time, despite this view not being supported by empirical evidence (Farooq et al, 2016). On occasion, the initial diagnosis of schizophrenia will be wrong, so regular diagnostic review especially in the first 6-12 months is essential.…”

Section: When Should the Diagnosis Of Schizophrenia Be Made?mentioning

confidence: 99%

“…On occasion, the initial diagnosis of schizophrenia will be wrong, so regular diagnostic review especially in the first 6-12 months is essential. The other reason appears to relate to the belief that disclosure of bad news will cause anguish and deny patients hope: this old fashioned view has been addressed by communication training for clinicians in physical medicine (Farooq et al, 2016).…”

Section: When Should the Diagnosis Of Schizophrenia Be Made?mentioning

confidence: 99%

See 1 more Smart Citation

The treatment of schizophrenia: Can we raise the standard of care?

Catts

O’Toole

2016

Aust N Z J Psychiatry

View full text Add to dashboard Cite

show abstract

Section: When Should the Diagnosis Of Schizophrenia Be Made?mentioning

confidence: 99%

Section: When Should the Diagnosis Of Schizophrenia Be Made?mentioning

confidence: 99%

The treatment of schizophrenia: Can we raise the standard of care?

Catts

O’Toole

2016

Aust N Z J Psychiatry

View full text Add to dashboard Cite

show abstract

“…As a basic ethical duty, the sharing of information concerning diagnoses of mental illnesses and outcomes should be part of any treatment plan from the earliest stages of any intervention. 3 However, studies conducted in Western and Asian countries indicate that low levels of knowledge about diagnoses exist among schizophrenic patients. 4 – 6 Educational initiatives relating to the treatment of schizophrenia-related disorders are often directed at family members and physicians, as patients with schizophrenia are viewed as being unable to make rational decisions.…”

Section: Introductionmentioning

confidence: 99%

Low level of knowledge regarding diagnosis and treatment among inpatients with schizophrenia in Shanghai

Huang¹,

Chiovenda²,

Shao³

et al. 2018

NDT

View full text Add to dashboard Cite

ObjectiveThe study was designed to measure the level of knowledge of the diagnosis of illness and its treatment among patients with schizophrenia in China, and to examine the association between the capacity to provide informed consent and participation in treatment.Participants and methodsA cross-sectional study was conducted at three clinical inpatient sites in Shanghai, China, during 2015. Patients’ knowledge of the illness, as well as the knowledge of the patients’ families and psychiatrists, was determined. Logistic regression was used to determine the factors associated with patients’ knowledge of schizophrenia.ResultsOut of 109 enrolled schizophrenic inpatients (mean age 42.46±1.29 years), 60.6% were aware of their diagnosis and 67.0% knew details of their treatment plan. The group with unimpaired capacity for giving informed consent had a greater knowledge of their diagnosis (χ2=5.002, p=0.038) and of their treatment plan (χ2=11.196, p<0.01) in comparison with patients who were regarded to be impaired. Using logistic regression analysis, it was found that patients’ capacity to give informed consent to treatment was associated with the level of knowledge surrounding the diagnosis (odds ratio =3.230, p<0.05) and the level of knowledge of treatment (odds ratio =4.962, p<0.01).ConclusionThe level of knowledge reported by inpatients with schizophrenia was low with respect to the diagnosis of schizophrenia and of the treatment associated with this illness. An association between patients’ capacities for giving informed consent and knowledge of their illness was confirmed in the present study. The results suggest that, in clinical practice, the informed consent process should be strengthened to protect the interests of patients with schizophrenia.

show abstract

“…Internationally, the use of guidelines and tools have been called for to support the process of diagnostic disclosure (Cleary et al 2009;Seeman, 2010;Milton & Mullan, 2014a, b;Farooq et al 2016;Villani & Kovess-Masféty, 2016). Some models have also been proposed to assist clinician training or to provide a communication tool to support discussions at the time of diagnosis.…”

Section: Introductionmentioning

confidence: 99%

“…2009; Seeman, 2010; Milton & Mullan, 2014 a , b ; Farooq et al . 2016; Villani & Kovess-Masféty, 2016). Some models have also been proposed to assist clinician training or to provide a communication tool to support discussions at the time of diagnosis.…”

Section: Introductionmentioning

confidence: 99%